The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSALV.L Regulatory News (SALV)

  • There is currently no data for SALV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appointment

4 Dec 2012 07:00

RNS Number : 6337S
3Legs Resources plc
04 December 2012
 



4 December 2012

 

 

3Legs Resources plc

 

Board Appointment

 

3Legs Resources plc (the "Company"), an independent oil and gas group focusing on the exploration and development of unconventional oil and gas resources, is pleased to announce the appointment of Richard Hills as a Non-Executive Director with immediate effect.

 

Richard (age 57) has over 30 years of experience in investment management and financial services, and is currently Head of Risk at Argyll Investment Services Ltd (Guernsey). Previously Richard has worked at a variety of large UK based investment management companies, including Aberdeen Asset Management Plc, as Head of UK equities and Chairman of the Investment Policy Committee, and Henderson Global Investors Plc, as Director of Henderson Administration Ltd, Henderson Pension Fund Management Ltd, Henderson International Inc. and a member of the Group Investment Policy Committee.

 

 

Current directorships

 

Directorships in the past five years

Aberdeen New Dawn Investment Trust plc

Henderson Global Trust plc

JP Morgan Income & Capital Investment Trust plc

Phaunos Timber Ltd

Cinven Ltd and Associated Funds

Aztec Group Ltd

Lord Hanson Charitable Trust

 

Institute for Quantitative Investment Research Ltd

FairFX Plc

Caspen Oil & Gas

 

 

 

In accordance with AIM Rule 17, there is nothing further to disclose under Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

Tim Eggar, Chairman of 3Legs Resources, said:

 

"I am delighted to welcome Richard to the board. His wealth of experience in the investment management and financial services spheres will bring additional insight to the 3Legs Board at this exciting and crucial period for the Company."

 

 

For further information contact:

 

3Legs Resources plc

Tel:

+44 1624 811 611

Kamlesh Parmar, Chief Executive Officer

Alexander Fraser, Chief Financial Officer

Jefferies Hoare Govett

Tel:

+44 207 029 8000

Simon Hardy

Jamie Buckland

College Hill

Tel:

+44 207 457 2020

Matthew Tyler

Catherine Wickman

 

 

 

Notes to Editors

 

3Legs Resources was established in early 2007 to focus on the exploration and development of unconventional oil and gas resources. A first mover in Poland, 3Legs Resources holds interests in six licences covering approximately 1,084,000 acres (gross) in the onshore Baltic Basin in northern Poland, a region considered to be one of the most promising shale basins in Europe. The Company also holds onshore exploration licences near Krakow in southern Poland and has licences in Baden-Württemberg in south-west Germany which are currently undergoing renewal.

 

The technical information and opinions contained in this announcement have been reviewed by John Blair (MSc in Geophysics, University of Tulsa and BSc in Geology from Montana State University), Exploration Manager of 3Legs Resources plc, who has over 25 years of experience in the oil exploration and production industry. He has consented to the inclusion herein of such technical information and opinions.

 

www.3legsresources.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBIBDDLGGBGDX
Date   Source Headline
9th Jan 20202:30 pmRNSCancellation of trading on AIM
20th Dec 201910:30 amRNSCancellation of AIM listing /Potential acquisition
27th Sep 201911:07 amRNSHalf-year Report - Correction
26th Sep 20192:06 pmRNSHalf-year Report
23rd Sep 20193:02 pmRNSAIM Rule 17 Notification
9th Jul 20197:30 amRNSSuspension - SalvaRx Group Plc
9th Jul 20197:30 amRNSSuspension of Trading
28th Jun 201911:26 amRNSFinal Results
31st Jan 20197:00 amRNSChange of Nominated Adviser and Broker
17th Jan 20192:05 pmRNSSecond Price Monitoring Extn
17th Jan 20192:00 pmRNSPrice Monitoring Extension
8th Jan 20194:15 pmRNSResult of AGM and Completion of Disposal
4th Jan 20195:30 pmRNSSalvarx Group
14th Dec 20187:50 amRNSNominated Adviser Status
10th Dec 20187:00 amRNSIssue of US$1 million of Loan Notes by iOx
27th Nov 20187:00 amRNSPosting of Circular and Notice of AGM
21st Nov 20181:00 pmRNSTransaction Update
6th Nov 20187:00 amRNSDirector/PDMR Dealing
22nd Oct 20189:47 amRNSIntensity Therapeutics Update
9th Oct 20187:00 amRNSExercise of Warrants
27th Sep 20187:00 amRNSHalf-year Report
28th Aug 20185:40 pmRNSUpdate re proposed disposal and demerger
14th Aug 20187:00 amRNSProposed disposal of interest in SalvaRx Limited
1st Aug 20184:40 pmRNSSecond Price Monitoring Extn
1st Aug 20184:35 pmRNSPrice Monitoring Extension
23rd Jul 20181:17 pmRNSDelay in iOx development programme
28th Jun 20187:00 amRNSFinal Results
26th Jun 20187:00 amRNSRelated Party Loan of US$1 million
8th Mar 201812:00 pmRNSDrug Pipeline Progress and iOx Loan Note Issue
30th Oct 20174:40 pmRNSSecond Price Monitoring Extn
30th Oct 20174:35 pmRNSPrice Monitoring Extension
23rd Oct 20177:00 amRNSSubscriptions for SalvaRx Ltd Loan Facility
27th Sep 20179:00 amRNSHalf-year Report
25th Sep 20178:00 amRNSFormation of Saugatuck Therapeutics
1st Aug 20173:30 pmRNSHolding(s) in Company
1st Aug 20173:30 pmRNSHolding(s) in Company
31st Jul 20171:45 pmRNSResult of AGM
5th Jul 20173:03 pmRNSNotice of AGM
30th Jun 20178:34 amRNSFinal Results
30th May 201712:45 pmRNSIntensity Therapeutics Treats First Patient
20th Mar 20177:00 amRNSInvestment in Rift Biotherapeutics
2nd Mar 20177:00 amRNSRestructuring, Loan Conversion and Loan Facility
28th Feb 20177:00 amRNSInvestment in Nekonal
2nd Feb 20174:37 pmRNSIntensity Therapeutics
3rd Oct 20164:40 pmRNSSecond Price Monitoring Extn
3rd Oct 20164:35 pmRNSPrice Monitoring Extension
14th Sep 20167:00 amRNSCorporate Video
13th Sep 20167:00 amRNSHalf-year Report
22nd Aug 20167:00 amRNSDrug Pipeline Progress including Patent Grants
4th Aug 20162:05 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.